VLP THERAPEUTICS LLC Email Format
Research ServicesMaryland, United States11-50 Employees
VLP Therapeutics LLC operates in the research services sector with a focus on cancer immunotherapies and vaccines. Based in Rockville, Maryland, the company has engaged in collaborative clinical development, including a Phase 1 trial of its cancer immunotherapy candidate VLPONC-01 in partnership with Stanford Medicine. The firm is a relatively small biotech organization pursuing early-stage oncology and immunology programs. The company has pursued vaccine-related initiatives as well, including a self-amplifying RNA vaccine project and a dengue vaccine development effort conducted with Nagasaki University. A Tokyo-based subsidiary has worked on a Covid-19 vaccine, reflecting the broader interest in infectious disease immunotherapy alongside cancer programs. Overall, VLP Therapeutics operates within the research services landscape, collaborating with academic and international partners to advance clinical-stage therapies.